A midstage clinical trial suggests that a “first-of-its-kind” treatment could prevent serious immune attacks from bone-marrow transplants.
Read The Full Article Here
A midstage clinical trial suggests that a “first-of-its-kind” treatment could prevent serious immune attacks from bone-marrow transplants.
Read The Full Article Here